Active Pharmaceutical Ingredients (API) Market: Applications and Growth Factors Analysis

An active pharmaceutical ingredient (API) is a drug or mixture of drugs applicable in a finished pharmaceutical product (FPP). API is a biologically active ingredient within the drug product intended for the treatment, diagnosis, or prevention of a disease. It is the definite component liable for the desired effect it has on the subject using it.
Rising prevalence of infectious diseases, cardiovascular conditions, and other chronic disorders among individuals globally is the major factor driving growth of the global market. In addition, due to rising prevalence of cancer, several manufacturers are focusing on development of highly potent APIs (HPAPI) and specialty APIs, thus boosting growth of the global market. According to data published by World health organization, cancer is the second leading cause of death globally and is projected to account for 9.6 million deaths in 2018. Furthermore, large numbers of drugs are in the pipeline to develop treatments for cancer, autoimmune disorder, and metabolic diseases. Increasing healthcare expenditure and rising geriatric population in developing countries are expected to enhance growth of the target market over the forecast period. However, increasing penetration of counterfeit drugs and unfavorable drug price control policies across various countries is expected to hamper growth of the global active pharmaceutical ingredients (API) market over the forecast period. Nevertheless, increasing demand toward the development of complex APIs used in novel formulations, targeting niche therapeutic areas is the major trend observed for the growth of the target market.
The global active pharmaceutical ingredients (API) market is segmented based of type, business mode, synthetic type, application, and region.
Based on type, the global active pharmaceutical ingredients (API) market is segmented into generic and branded. On the basis of business model, the global market is segmented into captive API and merchant API. On the basis of synthesis type, the global market is bifurcated into synthetic and biotech. Biotech synthesis type segment held the highest market share, owing to high demand for protein-based therapeutics and increasing focus of manufacturers toward biological drugs. Based on application, the target market is classified into Cardiology, Pulmonology, Oncology, Ophthalmology, Neurology, and Orthopedic. Cardiology application segment accounts for the highest growth due to increasing prevalence rate and high amount of product availability.


Contact Us:
Mr. Alex (Sales Manager)
Prophecy Market Insights
Phone: +1 860 531 2701
Connetct With Us:-

facebook 
linkedin
Twitter 

Comments

Post a Comment

Popular posts from this blog

North America Depression Therapeutics Market Analysis, Dynamics, Forecast and Supply Demand 2019-2029

Image
By Drug Type (Selective Serotonin Reuptake Inhibitors (SSRIs), Selective Norepinephrine Reuptake Inhibitors (SNRIs), and Others (Serotonin Modulators, Tricyclic & Tetracyclic Antidepressant and, Atypical Antidepressant)), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and By Country (U.S. and Canada) - Market Trends, Analysis, and Forecast till 2029 North America depression therapeutics market report published by Prophecy Market Insights offers holistic view of various influencing factors and aims to answer all the target market related questions. High awareness regarding depression and availability of drugs and therapies is the major driver for the target market growth. However, the patent cliff has caused a decline in the growth rates of the market. For instance, according to a data published by National Alliance on Mental Illness in 2019, 64.1% of U.S. adults with serious mental illness received treatment in 2018. However, patent cli...
Read more

Sickle Cell Disease Treatment Market With Four Main Geographies And Their Countries

Image
By Product (Hematology Analyzers, Flow Cytometers, Coagulation Analyzers, Slide Stainers, Centrifuges, Hemoglobin meters, Other Products), By Reagents (Coagulation Reagents, Flow Cytometer Reagents, Immuno-hematology Reagents, and Other Reagents), By Application (Drug Testing and Auto-Immune Disease), By End User (Hospitals, Clinical Testing Institutes, Patient Self-testing, and Other End Users), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030 Introduction: The pipeline for sickle cell disease comprises strong pharmaceutical companies with novel therapies in the late stages of clinical trials and various mid and small pharmaceutical companies with early-stage pipeline drugs. The strong efficacy of these drugs in the early stages of clinical trials has led to a positive opinion from the regulatory bodies. Thus, helping the vendors with the quick development of these drugs. Drivers and R...
Read more

Enasidenib Drugs Market Growth by 2029: PMI

Image
Global enasidenib drugs market report published by Prophecy Market Insights offers holistic view of various influencing factors and aims to answer all the target market related questions. The research scope provides comprehensive market size, and other in-depth market information details such as, market growth supporting factors, restraining factors, trends, opportunities, market risk factors, market competition, product and services advancements and launches, product/services related regulations overview, and recent developments for the mentioned forecast period. In addition, the report provides key examination of market players operating in the specific market and analysis and outcomes related with the target market for more than 20 countries. In the current research scope 2018 is considered as base year and 2019 is estimated year for market value/volume calculations. The report offers market estimates for the forecast period – 2019 to 2029. The report provides factual inputs...
Read more